Accéder au contenu
Merck

[Model of platelet activation as experimental test system for screening kappa-opioid receptor ligands].

Eksperimental'naia i klinicheskaia farmakologiia (2012-01-12)
A A Spasov, O Iu Grechko, V A Anisimova
RÉSUMÉ

A new model is proposed for in vitro testing the efficiency of new chemical substances with kappa-opioid receptor agonist ligand properties.